Anthea Cherednichenko: Over 70 Years of Supporting Hemophilia and Bleeding Disorders at Takeda
Anthea Cherednichenko, Vice President, Franchise Head of Hematology and Transplant, USBU at Takeda, shared Takeda’s post on LinkedIn, adding:
”For over 70 years teams at Takeda have been supporting people living with hemophilia and bleeding disorders.
On WHD, I want to express my gratitude for all of these teams today, and over the years, for their commitment. And to the members of this community who inspire us, collaborate with us, and trust us to be part of your journey – thank you.
Your resilience, courage, and advocacy continue to drive progress and remind us why this work matters.
Together, we remain committed to advancing care, expanding possibilities, and helping create a better future for everyone affected by bleeding disorders.”
Takeda, shared a post on LinkedIn:
”A timely and accurate diagnosis is a critical first step in helping people living with hemophilia access the support and care they need.
Today on World Hemophilia Day, we join the global hemophilia community in recognizing the critical need for efforts that advance awareness and education to ultimately speed time to an accurate diagnosis.
This mission guides us as we engage with healthcare professionals, people with bleeding disorders and stakeholders from around the world at the World Federation of Hemophilia 2026 World Congress in Malaysia.
We look forward to discussing how to advance our shared goal of improving care for this community.”
Stay updated with Hemostasis Today.
-
Jun 22, 2026, 16:45Shivangi Harankhedkar: Gene Therapy and CRISPR Advances in Hemoglobinopathies
-
Jun 22, 2026, 16:39Vikram Sinai Talaulikar: Haematology and Female Hormone Health Intersect at Multiple Levels
-
Jun 22, 2026, 16:35Sehrish Chaudhary: Advancing Transfusion Medicine Through Global Collaboration at ISBT 2026
-
Jun 22, 2026, 15:54Ready to Build Your ISTH 2026 Schedule?
-
Jun 22, 2026, 15:36Wolfgang Miesbach: What the Latest Gene Therapy Setbacks Mean for Haemophilia Care
-
Jun 22, 2026, 15:26Suvro Sankha Datta: Advancing Transfusion Medicine Through the Establishment of a Red Cell Genotyping Facility
-
Jun 22, 2026, 15:08Apixaban vs. Rivaroxaban in Acute VTE – Uncoiling COBRRA and Its Clinical Implications – Anticoagulation Forum
-
Jun 22, 2026, 14:41Ilkin Aygun Soyalp: Novel Substrate Recognition Broadens the Biological Role of DPF-3
-
Jun 22, 2026, 14:29Swarnava Roy: Linking Angiotensin Signaling to Oxidative Stress and Organ Damage in Sickle Cell Anemia